Molecular targeting therapy for pancreatic cancer: Current knowledge and perspectives from bench to bedside

Research output: Contribution to journalReview articlepeer-review

42 Citations (Scopus)

Abstract

Current medical interventions for pancreatic cancer are insufficient. Recent molecular investigations have elucidated complex genetic mechanisms of cancer that especially involve multiple signal transduction pathways; this enables us to develop molecular medicines targeting specific genetic molecules in the pathways. These molecular medicines seem to promise clues for curing cancers, including pancreatic cancer. This review describes current knowledge and perspectives regarding the development of molecular medicines for pancreatic cancer by focusing on growth factor receptor systems and three major signal transduction pathways: the RAS-MAPK, PI3K-AKT-mTOR, and hedgehog pathways.

Original languageEnglish
Pages (from-to)905-911
Number of pages7
JournalJournal of gastroenterology
Volume43
Issue number12
DOIs
Publication statusPublished - 2008 Dec 1
Externally publishedYes

Keywords

  • Hedgehog
  • Molecular targeting
  • PI3K-AKT
  • Pancreatic cancer
  • RAS-MAPK

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Molecular targeting therapy for pancreatic cancer: Current knowledge and perspectives from bench to bedside'. Together they form a unique fingerprint.

Cite this